CoChat

RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma

Houles, Thibault, Gravel, Simon-Pierre, Lavoie, Geneviève, Shin, Sejeong, Savall, Mathilde, Méant, Antoine, Grondin, Benoit, Gaboury, Louis, Yoon, Sang-Oh, St-Pierre, Julie, Roux, Philippe P. · 2018 · Cancer Research
Cited by 64

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Metabolic reprogramming is a hallmark of cancer that includes increased glucose uptake and accelerated aerobic glycolysis. This phenotype is required to fulfill anabolic demands associated with aberrant cell proliferation and is often mediated by oncogenic drivers such as activated BRAF. In this study, we show that the MAPK-activated p90 ribosomal S6 kinase (RSK) is necessary to maintain glycolytic metabolism in BRAF-mutated melanoma cells. RSK directly phosphorylated the regulatory domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (PFKFB2), an enzyme that catalyzes the synthesis of fructose-2,6-bisphosphate during glycolysis. Inhibition of RSK reduced PFKFB2 activity and glycolytic flux in melanoma cells, suggesting an important role for RSK in BRAF-mediated metabolic rewiring. Consistent with this, expression of a phosphorylation-deficient mutant of PFKFB2 decreased aerobic glycolysis and reduced the growth of melanoma in mice. Together, these results indicate that RSK-mediated phosphorylation of PFKFB2 plays a key role in the metabolism and growth of BRAF-mutated melanomas. Significance: RSK promotes glycolytic metabolism and the growth of BRAF-mutated melanoma by driving phosphorylation of an important glycolytic enzyme. Cancer Res; 78(9); 2191–204. ©2018 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-17-2215

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 64

Metadata

Authors
Houles, T., Gravel, S.-P., Lavoie, G., Shin, S., Savall, M., Méant, A., Grondin, B., Gaboury, L., Yoon, S.-O., St-Pierre, J., & Roux, P. P.
Venue
Cancer Research
Published
2018-04-30
Volume
78
Issue
9
Pages
2191-2204
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2794210822
Cited by
64
References
13
FWCI
1.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma. https://app.cochat.ai/papers/10.1158/0008-5472.can-17-2215
The paper
Houles, T., Gravel, S.-P., Lavoie, G., Shin, S., Savall, M., Méant, A., Grondin, B., Gaboury, L., Yoon, S.-O., St-Pierre, J., & Roux, P. P. (2018). RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma. Cancer Research. https://doi.org/10.1158/0008-5472.can-17-2215

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.